Buell Jennifer
SEC CIK 1711184 · EDGAR
Most active insiders at INKT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Ryan Barbara | Dir | — | $46.6K |
| 2 | Holcomb John Bradley | Dir | — | — |
| 3 | Kadlec Robert Peter | Dir | — | — |
| 4 | Behner Peter | Dir | — | — |
| 5 | Buell Jennifer | CEO | — | — |
| 6 | Corvese Brian | Dir | — | — |
| 7 | WIINBERG ULF | Dir | — | — |
Transactions 19
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2026-01-14 | 2026-01-02 | INKT | MiNK Therapeutics, Inc. | Buell Jennifer | CEO | F - Tax | $11.12 | -10.0K | 57.9K | -15% | -$111.5K |
| D | 2026-01-06 | 2026-01-02 | INKT | MiNK Therapeutics, Inc. | Buell Jennifer | CEO | A - Grant | $11.12 | +31.5K | 68.0K | +86% | +$350.0K |
| A | 2025-10-03 | 2025-09-09 | INKT | MiNK Therapeutics, Inc. | Buell Jennifer | CEO | F - Tax | $15.36 | -5,351 | 36.5K | -13% | -$82.2K |
| D | 2025-09-11 | 2025-09-09 | INKT | MiNK Therapeutics, Inc. | Buell Jennifer | CEO | A - Grant | $15.36 | +18.2K | 41.9K | +77% | +$280.0K |
| 2025-05-06 | 2025-05-02 | AGEN | AGENUS INC | Buell Jennifer | Dir | A - Grant | $3.11 | +581 | 19.7K | +3% | +$1,807 | |
| 2025-05-05 | 2025-04-18 | AGEN | AGENUS INC | Buell Jennifer | Dir | A - Grant | $2.08 | +869 | 19.2K | +5% | +$1,808 | |
| 2025-04-10 | 2025-04-04 | AGEN | AGENUS INC | Buell Jennifer | Dir | A - Grant | $1.56 | +1,159 | 18.3K | +7% | +$1,808 | |
| 2025-03-27 | 2025-03-21 | AGEN | AGENUS INC | Buell Jennifer | Dir | A - Grant | $1.61 | +1,123 | 17.1K | +7% | +$1,808 | |
| 2025-03-24 | 2025-03-07 | AGEN | AGENUS INC | Buell Jennifer | Dir | A - Grant | $2.35 | +409 | 15.6K | +3% | +$961.15 | |
| 2025-03-11 | 2025-02-21 | AGEN | AGENUS INC | Buell Jennifer | Dir | A - Grant | $3.32 | +545 | 15.2K | +4% | +$1,809 | |
| 2025-03-05 | 2025-02-21 | AGEN | AGENUS INC | Buell Jennifer | Dir | A - Grant | $3.32 | +626 | 15.3K | +4% | +$2,078 | |
| 2025-02-18 | 2025-02-07 | AGEN | AGENUS INC | Buell Jennifer | Dir | A - Grant | $3.50 | +516 | 14.7K | +4% | +$1,806 | |
| 2025-02-04 | 2025-01-24 | AGEN | AGENUS INC | Buell Jennifer | Dir | F - Tax | $3.57 | -270 | 14.2K | -2% | -$963.90 | |
| 2025-01-28 | 2025-01-24 | AGEN | AGENUS INC | Buell Jennifer | Dir | A - Grant | $3.57 | +776 | 14.4K | +6% | +$2,770 | |
| D | 2023-10-13 | 2023-10-11 | INKT | MiNK Therapeutics, Inc. | Buell Jennifer | CEO, Dir | J - Other | — | -695.8K | 232.2K | -75% | — |
| M | 2023-10-03 | 2023-09-29+ | INKT | MiNK Therapeutics, Inc. | Buell Jennifer | CEO, Dir | F - Tax | $1.01 | -148.6K | 992.9K | -13% | -$150.7K |
| D | 2023-09-29 | 2023-09-27 | INKT | MiNK Therapeutics, Inc. | Buell Jennifer | CEO | M - OptEx | — | +695.8K | 1.08M | +183% | — |
| D | 2023-01-11 | 2023-01-09 | INKT | MiNK Therapeutics, Inc. | Buell Jennifer | CEO | A - Grant | $2.32 | +172.0K | 380.7K | +82% | +$399.0K |
| D | 2021-07-02 | 2021-06-30 | AGEN | AGENUS INC | Buell Jennifer | COO, Pres | A - Grant | $5.49 | +10.6K | 127.1K | +9% | +$58.2K |
Purchase Sale Sale after option exercise All abbreviations